Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
ABNR/X Capital was established in 1998 and is headquartered in Tel Aviv, Israel. The firm focuses on investing in early-stage and growth-stage high-tech companies, particularly those that leverage breakthrough technologies. ABNR/X Capital operates globally, with additional office locations in Seattle, USA; Dubai, UAE; and São Paulo, Brazil. This geographic diversity allows the firm to tap into various markets and identify innovative startups across different regions.
Throughout its history, ABNR/X Capital has positioned itself as a facilitator in the capital markets, promoting and marketing businesses to potential investors. The firm emphasizes the importance of strong intellectual property in its investment strategy, aiming to support companies that can deliver unique solutions to large markets. This focus on intellectual property is crucial for maintaining a competitive edge in the fast-paced technology sector.
ABNR/X Capital targets startups that possess innovative technologies addressing substantial market needs. The firm emphasizes investments in companies with significant intellectual property positions, which are essential for maintaining a competitive advantage. Their investment strategy spans various stages, including Pre-seed, Seed, Seed+ (Extension), Series A, Series B, and Growth Equity.
Geographically, ABNR/X Capital operates on a global scale, with a particular focus on North America, Europe, Asia, and Latin America. The firm seeks to identify high-tech companies that can provide unique solutions to large markets, enhancing their competitive edge and time-to-market advantage. This strategic focus allows ABNR/X Capital to align with startups that have the potential for significant growth and impact.
Startups can pitch to ABNR/X Capital through their website at abnrx.com. It is recommended to include details about the technology, market potential, and intellectual property in the pitch deck. The firm values clear communication of the startup's unique advantages and competitive positioning.
What are ABNR/X Capital's investment criteria?
ABNR/X Capital invests in early-stage and growth-stage high-tech companies that leverage breakthrough technologies. They specifically look for startups with strong intellectual property positions that can provide a competitive advantage in large markets.
How can startups apply or pitch to ABNR/X Capital?
Startups interested in pitching to ABNR/X Capital can visit their website at abnrx.com for more information. The firm encourages startups to present their innovative technologies and intellectual property strengths during the pitch.
What makes ABNR/X Capital different from other venture capital firms?
ABNR/X Capital differentiates itself by focusing on high-tech startups with significant intellectual property. Their expertise in capital markets and investor networks allows them to promote and market businesses effectively to potential investors.
What is the geographic scope of ABNR/X Capital's investments?
ABNR/X Capital operates globally, with a focus on North America, Europe, Asia, and Latin America. This broad geographic reach enables them to identify innovative startups across various markets.
What is ABNR/X Capital's approach to post-investment involvement?
ABNR/X Capital provides its expertise and investor network to support portfolio companies in negotiations and commercial transactions. They facilitate connections with potential investors to enhance the growth of their portfolio companies.
What is the typical check size for investments made by ABNR/X Capital?
The specific check sizes are not disclosed, but ABNR/X Capital invests across various stages, including Pre-seed, Seed, Series A, and Growth Equity, indicating a flexible approach to funding.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.